Summit Therapeutics SMMT Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's total current assets?
- Summit Therapeutics (SMMT) reported total current assets of $616.6M in Q1 2026.
- How has Summit Therapeutics's total current assets changed year-over-year?
- Summit Therapeutics's total current assets increased by 66.3% year-over-year, from $370.75M to $616.6M.
- What is the long-term trend for Summit Therapeutics's total current assets?
- Over 5 years (2020 to 2025), Summit Therapeutics's total current assets has grown at a 52.4% compound annual growth rate (CAGR), from $87.67M to $720.3M.
- What does total current assets mean?
- The total value of all assets that can be turned into cash within one year.
- How do you interpret total current assets?
- Higher levels indicate stronger short-term solvency and operational flexibility.
- How does total current assets compare across companies?
- Crucial for comparing the financial runway of companies in the same clinical development phase.